Pennsylvania Code
Pennsylvania Code & Bulletin
COMMONWEALTH OF PENNSYLVANIA

• No statutes or acts will be found at this website.

The Pennsylvania Bulletin website includes the following: Rulemakings by State agencies; Proposed Rulemakings by State agencies; State agency notices; the Governor’s Proclamations and Executive Orders; Actions by the General Assembly; and Statewide and local court rules.

PA Bulletin, Doc. No. 06-1031

NOTICES

Medical Assistance Program; Prior Authorization List

[36 Pa.B. 2867]
[Saturday, June 10, 2006]

   Section 443.6(b)(7) of the Public Welfare Code (62 P. S. § 443.6(b)(7)) authorizes the Department of Public Welfare (Department) to add items and services to the Medical Assistance (MA) Program's list of services that require prior authorization by publication of notice in the Pennsylvania Bulletin.

   The purpose of this notice is to announce that the Department has added prescriptions, including refills, for Botox, Synagis and Xolair to the MA Program's list of services that require prior authorization.

Fiscal Impact

   The savings associated with the addition of these drugs to the prior authorization list are estimated at $0.303 million ($0.136 million in State funds) in Fiscal Year (FY) 2005-2006. Annualized savings of $1.903 million ($0.865 million in State funds) are estimated in FY 2006-2007.

Public Comment

   Interested persons are invited to submit written comments regarding this notice to the Department of Public Welfare, Office of Medical Assistance Programs, c/o Deputy Secretary's Office, Attention: Regulations Coordinator, Room 515, Health and Welfare Building, Harrisburg, PA 17120. Comments received within 30 days will be reviewed and considered for any subsequent changes to these prior authorization requirements.

   Persons with a disability who require an auxiliary aid or service may submit comments using the AT&T Relay Service at (800) 654-5984 (TDD users) or (800) 654-5988 (voice users).

ESTELLE B. RICHMAN,   
Secretary

   Fiscal Note:  14-NOT-477. No fiscal impact; (8) recommends adoption. Savings associated with adding these drugs to the prior authorization list are estimated at $.136 million for Fiscal Year 05-06 and $.865 million for 06-07.

[Pa.B. Doc. No. 06-1031. Filed for public inspection June 9, 2006, 9:00 a.m.]


No part of the information on this site may be reproduced for profit or sold for profit.

This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.